Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 4/20 | 0.46 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.36 |
| ▸ | TYMS | P04818 | 1/20 | 0.36 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.34 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL132769 | 0.97 | FDPS (0.44) | FDPSGGPS1TYMSS1PR2S1PR1 | |
| SCHEMBL10771002 | 0.97 | FDPS (0.44) | FDPSGGPS1TYMSS1PR2S1PR1 | |
| SCHEMBL5162009 | 0.94 | FDPS (0.46) | FDPSGGPS1TYMSKDM4EMMP2 | |
| SCHEMBL12231293 | 0.89 | FDPS (0.39) | FDPSGGPS1S1PR2S1PR1S1PR3 | |
| SCHEMBL38156 | 0.88 | FDPS (0.50) | FDPSTYMSKDM4EMMP2THRB | |
| SCHEMBL1614430 | 0.87 | FDPS (0.41) | FDPSTYMS | |
| SCHEMBL1421092 | 0.87 | GGPS1 (0.55) | FDPSGGPS1S1PR2S1PR1S1PR3 | |
| SCHEMBL11080232 | 0.87 | GGPS1 (0.55) | FDPSGGPS1S1PR2S1PR1S1PR3 | |
| SCHEMBL11765105 | 0.87 | GGPS1 (0.55) | FDPSGGPS1S1PR2S1PR1S1PR3 | |
| Water SCHEMBL7073557 | 0.86 | FDPS (0.48) | FDPSTYMSKDM4EMMP2THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023227357-A1 | COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2023-11-30 | — | — | WO | claimed |
| US-11591281-B1 | Method of peroxylactic acid production and use for reduction in microbial activity in food product processing | ZEE COMPANY I, LLC (US) | 2023-02-28 | — | — | US | claimed |
| US-11130707-B2 | Hydrating swellable clays | HALLIBURTON ENERGY SERVICES, INC. (US) | 2021-09-28 | — | — | US | claimed |
| EP-3441368-B1 | WATER TREATMENT METHOD | TORAY INDUSTRIES (JP) | 2021-07-07 | — | — | EP | claimed |
| US-10919831-B1 | Method of peroxylactic acid production and use for reduction in microbial activity in food product processing | ZEE COMPANY, INC. (US) | 2021-02-16 | — | — | US | claimed |
| US-10876083-B2 | Brewing vessel cleaning composition and related methods of use | ZEE COMPANY, INC. (US) | 2020-12-29 | — | — | US | claimed |
| WO-2020243788-A1 | EXPLOSIVES BASED ON HYDROGEN PEROXIDE WITH IMPROVED SLEEP TIME | CMTE DEVELOPMENT LIMITED (AU) | 2020-12-10 | — | — | WO | claimed |
| US-20200283336-A1 | Hydrating Swellable Clays | HALLIBURTON ENERGY SERVICES, INC. (US) | 2020-09-10 | — | — | US | claimed |
| US-10745338-B1 | Method of peroxylactic acid production and use for reduction in microbial activity in food product processing | ZEE COMPANY, INC. (US) | 2020-08-18 | — | — | US | claimed |
| US-10723939-B2 | Methods and compositions for treating a subterranean formation with a polymeric additive composite | HALLIBURTON ENERGY SERVICES, INC. (US) | 2020-07-28 | — | — | US | claimed |
| US-10703676-B2 | Hydrating swellable clays | HALLIBURTON ENERGY SERVICES, INC. (US) | 2020-07-07 | — | — | US | claimed |
| US-20190225542-A1 | Hydrating Swellable Clays | HALLIBURTON ENERGY SERVICES, INC. (US) | 2019-07-25 | — | — | US | claimed |
| US-20190093007-A1 | Methods and Compositions for Treating a Subterranean Formation with a Polymeric Additive Composite | HALLIBURTON ENERGY SERVICES, INC. (US) | 2019-03-28 | — | — | US | claimed |
| EP-3441368-A1 | WATER TREATMENT METHOD AND WATER TREATMENT DEVICE | Toray Industries, Inc. (JP) | 2019-02-13 | — | — | EP | claimed |
| WO-2018071021-A1 | HYDRATING SWELLABLE CLAYS | HALLIBURTON ENERGY SERVICES, INC. (US) | 2018-04-19 | — | — | WO | claimed |
| WO-2017202922-A1 | LAUNDRY COMPOSITION | UNILEVER PLC (GB) | 2017-11-30 | — | — | WO | claimed |
| EP-2898775-B1 | Alcohol-based disinfectant | DR SCHUMACHER GMBH (DE) | 2017-11-01 | — | — | EP | claimed |
| EP-4158081-B1 | METHOD FOR PROVIDING CORROSION PROTECTION TO A PRESSURIZED WATER-STEAM SYSTEM | KURITA WATER IND LTD (JP) | 2024-07-17 | — | — | EP | disclosed |
| US-20090294082-A1 | PREVENTION OF BACTERIAL SPORE FORMATION IN A BROKE SYSTEM OF A BOARD MACHINE | KEMIRA OYJ (FI) | 2009-12-03 | — | — | US | disclosed |
| EP-0861656-A1 | Hair bleaching composition | Wella Aktiengesellschaft (DE) | 1998-09-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10745338-B1 | Method of peroxylactic acid production and use for reduction in microbial activity in food product processing | LCT, APEH, LPO | FDPS 2086/4885GGPS1 1854/4885TYMS 3865/4885 |
| US-11591281-B1 | Method of peroxylactic acid production and use for reduction in microbial activity in food product processing | LCT, APEH, LPO | FDPS 2086/4885GGPS1 1854/4885TYMS 3865/4885 |
| US-10919831-B1 | Method of peroxylactic acid production and use for reduction in microbial activity in food product processing | LCT, APEH, LPO | FDPS 2086/4885GGPS1 1854/4885TYMS 3865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.